First Surgery With Polymer-Based Coil Takes Place, Using Embolization, Inc., Device

November 10, 2025 UCBN News, Syndication Comments Off on First Surgery With Polymer-Based Coil Takes Place, Using Embolization, Inc., Device

— Polymer-based coil minimizes artifacts in imaging — BOULDER, Colo., Nov. 10, 2025 /PRNewswire/ — A woman in Delaware has become the first patient to undergo minimally invasive, endovascular surgery with a polymer-based coil. The coil, manufactured by Embolization, Inc., is a vascular…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks

Related Articles

No Picture
News

Sierra Space Commences Final Testing and Launch Preparations for Dream Chaser® Spaceplane at NASA’s Kennedy Space Center

August 2, 2024 UCBN News, Syndication Comments Off on Sierra Space Commences Final Testing and Launch Preparations for Dream Chaser® Spaceplane at NASA’s Kennedy Space Center

LOUISVILLE, Colo.–(BUSINESS WIRE)–Sierra Space, a leading commercial space-tech company that is Building a Platform in Space to Benefit Life on Earth®, announced today that final testing and launch preparations for its Dream Chaser® spaceplane and […]

No Picture
News

GHX Announces CEO Succession

September 20, 2022 UCBN News Comments Off on GHX Announces CEO Succession

President and CEO Bruce Johnson to Transition to Executive Chairman of the Board; Tina Vatanka Murphy Appointed Successor LOUISVILLE, Colo., Sept. 20, 2022 /PRNewswire/ — Global Healthcare Exchange (GHX) announced today that Bruce Johnson will […]

No Picture
News

BioLoomics Raises $8.7 Million Seed Round to Develop Target Degrading Antibodies

September 19, 2023 UCBN News, Syndication Comments Off on BioLoomics Raises $8.7 Million Seed Round to Develop Target Degrading Antibodies

BOULDER, Colo.–(BUSINESS WIRE)–BioLoomics, the company pioneering directed evolution of target degrading antibodies using human cells, today announced it has raised $8.7 million in seed financing to advance its proprietary platform technology and antibody degrader programs. […]